Knowledge at the heart of leadership
Welcome to Liftstream - Life Sciences Executive Search and Leadership Advisory

10 companies driving forward the rare disease market

Authored by Liftstream In recognition of Rare Disease Day 2013 Liftstream has chosen to profile 10 highly innovative biotech companies which are highly active in rare disease research and development. The companies analysed range from those with marketed products to companies … Continue reading

Posted in Orphan Drugs and Rare Diseases | Tagged , , , , , , , , , , , , , , , | Leave a comment

PTC Therapeutics opts for conditional approach in Duchenne

Authored by Paul Foster As part of Liftstream’s commitment to rare diseases, in the run up to Rare Disease Day 2013 we will be profiling 10 companies that are leading rare disease research. In the tenth in the series we look at … Continue reading

Posted in Orphan Drugs and Rare Diseases | Tagged , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Prosensa & GSK pool resources to drive Drisapersen in Duchenne

Authored by Karl Simpson As part of Liftstream’s commitment to rare diseases, in the run up to Rare Disease Day 2013 we will be profiling 10 companies that are leading rare disease research. In the ninth in the series we look at Dutch … Continue reading

Posted in Orphan Drugs and Rare Diseases | Tagged , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Sarepta’s hopes high for first Duchenne (DMD) therapy

Authored by James Sheppard As part of Liftstream’s commitment to rare diseases, in the run up to Rare Disease Day 2013 we will be profiling 10 companies that are leading rare disease research. In the eighth in the series we … Continue reading

Posted in Orphan Drugs and Rare Diseases | Tagged , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Synageva offering LSD patients renewed hope

Authored by James Sheppard As part of Liftstream’s commitment to rare diseases, in the run up to Rare Disease Day 2013 we will be profiling 10 companies that are leading the rare disease research effort. In the seventh of the … Continue reading

Posted in Orphan Drugs and Rare Diseases | Tagged , , , , , , , , , , , , , , , | Leave a comment

Funding successes allow Promethera to look to clinical data in 2013

Authored by James Sheppard As part of Liftstream’s commitment to rare diseases, in the run up to Rare Disease Day 2013 we will be profiling 10 companies that are highly active in rare disease research. In the sixth in the … Continue reading

Posted in Orphan Drugs and Rare Diseases | Tagged , , , , , , , , , , , , , , , , , , | 1 Comment

Ultragenyx focused on ultra-rare disease future

Authored by Paul Foster As part of Liftstream’s commitment to rare diseases, in the run up to Rare Disease Day 2013 we will be profiling 10 companies that are leading the rare disease research effort. In the 5th of the … Continue reading

Posted in Orphan Drugs and Rare Diseases | Tagged , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Oxyrane seeking to advance Pompe Disease programme in 2013

Authored by James Sheppard As part of Liftstream’s commitment to rare diseases, in the run up to Rare Disease Day 2013 we will be showcasing 10 companies that are leading rare disease research. In the fourth of the series we … Continue reading

Posted in Orphan Drugs and Rare Diseases | Tagged , , , , , , , , , , , , , , , , , , , , | Leave a comment

Aegerion brings new hope to HoFH patients

Authored by Karl Simpson As part of Liftstream’s commitment to rare diseases, in the run up to Rare Disease Day 2013 we will be profiling 10 companies that are active in rare disease research. In the third of the series we look … Continue reading

Posted in Orphan Drugs and Rare Diseases | Tagged , , , , , , , , , , , , , | Leave a comment

Roche Snags Phase III Agromegaly Drug from Chiasma

Roche have announced they have acquired the rights to a phase III oral Agromegaly drug Octreolin from, Israeli biotech, Chiasma. Agromegaly is a rare progressive disease caused by the over production of growth hormone resulting in severe disfigurement. Agromegaly is … Continue reading

Posted in M&A Finance and Funding | Tagged , , , , , , , , , , , | Leave a comment




Contact Us

   Liftstream Ltd.
67 Grosvenor Street
London
W1K 3JN

   Tel: ​+44 (0)20 3178 5864
   info@liftstream.com

Register your CV

Apply for sector specific vacancies or request a confidential discussion



Registered in England No: 5009233
VAT: 843679292

Follow Us





Sitemap